肾性继发性甲状旁腺功能亢进症的多学科协作治疗

摘要/Abstract

中图分类号:

R653

陈海珍, 陈曦. 肾性继发性甲状旁腺功能亢进症的多学科协作治疗[J]. 外科理论与实践, 2018, 23(02): 103-107.

[1] 陈孜瑾, 蒋钻红, 汪知玉, 等. 超声评估维持性血液透析患者甲状旁腺增生的临床价值和相关因素分析[J]. 中国血液净化,2017,16(2):108-112.
[2] Okada M, Tominaga Y, Hiramitsu T, et al.Development of severe hyper-parathyroidism despite short-term renal replacement therapy[J]. World J Surg,2018,42(2):425-430.
[3] Zhang L, Fang W, Li W, et al.Prevalence of chronic kidney disease in China[J]. Lancet,2012,379(9818):815-822.
[4] 张凌, 常靓. 西那卡塞在CKD-MBD 中的应用[J]. 临床药物治疗杂志,2017,15(4):7-10.
[5] Kidney DiseaseI improving Global outcomes (KDIGO) CKD-MBD Work Group. Clinical practice guideline for the diagnosis, evaluation, prevention and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)[J]. Kidney Int Suppl,2009,76(Suppl 113):S1-S130.
[6] 中华医学会肾脏病学分会. 慢性肾脏病矿物质和骨异常诊治指导[J]. 肾脏病与透析肾移植杂志,2013,22(6):554-559.
[7] 薄天慧, 赵伟, 高秀. 高通量血液透析联合血液灌流对维持性血液透析患者血清钙、磷及甲状旁腺激素代谢的影响[J]. 国际移植与血液净化杂志,2017,15(4):34-36.
[8] Floege J, Kubo Y, Floege A, et al.The effect of cinacalcet on calcific uremic arteriolopathy events in patients receiving hemodialysis: The EVOLVE trial[J]. Clin J Am Soc Nephrol,2015,10(5):800-807.
[9] van der Plas WY, Engelsman AF, Özyilmaz A, et al. Impact of the introduction of calcimimetics on timing of parathyroidectomy in secondary and tertiary hyperparathyroidism[J]. Ann Surg Oncol,2017,24(1):15-22.
[10] Isaksson E, Ivarsson K, Akaberi S, et al.The effect of parathyroidectomy on risk of hip fracture in secondary hyperparathyroidism[J]. World J Surg,2017,41(9):2304-2311.
[11] Iwamoto N, Sato N, Nishida M, et al.Low parathyroid hormone levels after parathyroidectomy reduce cardiovascular mortality in chronic hemodialysis patients[J]. Clin Exp Nephrol,2016,20(5):808-814.
[12] Chen L, Wang K, Yu S, et al.Long-term mortality after parathyroidectomy among chronic kidney disease patients with secondary hyperparathyroidism: a systematic review and meta-analysis[J]. Ren Fail,2016,38(7):1050-1058.
[13] Apetrii M, Goldsmith D, Nistor I, et al.Impact of surgical parathyroidectomy on chronic kidney disease-mineral and bone disorder(CKD-MBD)- A systematic review and meta-analysis[J]. PLoS One,2017,12(11):e0187025.
[14] Schneider R, Kolios G, Koch BM, et al.An economic comparison of surgical and medical therapy in patients with secondary hyperparathyroidism-the German prospective[J]. Surgery,2010,148(6):1091-1099.
[15] van der Plas WY, Dulfer RR, Engelsman AF, et al. Effect of parathyroidectomy and cinacalcet on quality of life in patients with end-stage renal disease-related hyperparathyroidism: a systematic review[J]. Nephrol Dial Transplant,2017,32(11):1902-1908.
[16] Fülöp T, Koch CA, Farah Musa AR, et al. Targeted surgical parathyroidectomy in end-stage renal disease patients and long-term metabolic control: A single-center experience in the current era[J]. Hemodial Int,2018-02-15 [Epub ahead of print]
[17] 杨镇玮, 白超, 罗军. 手术与拟钙剂治疗难治性SHPT的短期疗效比较[J]. 重庆医学,2017,46(9):1214-1219.
[18] Fukagawa M, Yokoyama K, Koiwa F, et al.Clinical practice guideline for the management of chronic kidney disease mineral and bone disorder[J]. Ther Apher Dial,2013,17(3):247-288.
[19] 中国医师协会外科医师分会甲状腺外科医师委员会, 中国研究型医院学会甲状腺疾病专业委员会. 慢性肾功能衰竭继发甲状旁腺功能亢进外科临床实践专家共识[J]. 中国实用外科杂志,2016,36(5):481-486.
[20] Kravietz AM, Buicko JL, Parreco JP, et al. Thirty-day readmissions following parathyroidectomy: Evidence from the National Readmissions Database, 2013-2014[J]. Am J Otolaryngol,2018-01-10[Epub ahead of print]
[21] Doyle DJ, Garmon EH.American Society of Anesthesio-logists Classification(ASA Class)[M]. Treasure Island (FL): Stat Pearls Publishing,2018.
[22] 杨猛, 张凌, 黄林平, 等. 无自体移植的甲状旁腺全切除术在难治性继发性甲状旁腺功能亢进中的应用[J]. 中国现代普通外科进展,2017,20(5):342-345.
[23] 梁伟, 李朋, 熊子波, 等. 维持性透析患者甲状旁腺切除术后低钙血症相关因素分析[J]. 中国血液净化,2017,16(2):91-94.
[24] Chan GC, Lee PC, Kwan LP, et al.Acute thyroiditis: An under-recognized complication of parathyroidectomy in end-stage renal failure patients with secondary hyperparathyroidism[J]. Nephrology (Carlton),2017,22(7):572.
[25] 章建全, 仇明, 盛建国, 等. 超声引导下经皮穿刺热消融治疗甲状旁腺结节[J]. 第二军医大学学报,2013,34(4):362-370.
[26] 麻昊旸, 程晨, 王宁宁, 等. 甲状旁腺热消融术治疗严重继发性甲状旁腺功能亢进[J]. 肾脏病与透析肾移植杂志,2017,26(4):370-375.
[27] Kim SM, Long J, Montez-Rath ME, et al.Rates and outcomes of parathyroidectomy for secondary hyperparathyroidism in the United States[J]. Clin J Am Soc Nephrol,2016,11(7):1260-1267.

肾性继发性甲状旁腺功能亢进症的多学科协作治疗

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章15

编辑推荐

Metrics

本文评价

[1]	章晓炎, 徐静, 璩斌.血清维生素D水平对老年慢性肾脏病患者肾功能的影响[J]. 内科理论与实践, 2022, 17(04): 307-312.
[2]	冯浩, 吕子成, 夏强.肝癌肝移植全过程管理及治疗进展[J]. 外科理论与实践, 2022, 27(02): 119-122.
[3]	轩应利, 陈斐虹, 秦丽, 和瑞斌, 庞诗情, 袁江姿.维生素D与慢性肾脏病患者夜间血压的相关性分析[J]. 内科理论与实践, 2021, 16(04): 246-250.
[4]	杨聚荣, 林利容.慢性肾脏病患者妊娠的管理现状及策略[J]. 诊断学理论与实践, 2021, 20(02): 125-129.
[5]	范秋灵.糖尿病肾病和非糖尿病慢性肾脏病患者应用钠-葡萄糖协同转运蛋白2抑制剂：预后评估及相关指南解读[J]. 诊断学理论与实践, 2021, 20(02): 130-137.
[6]	陈晓农, 高琛妮.肾性贫血的诊治进展[J]. 内科理论与实践, 2021, 16(01): 10-14.
[7]	晏焕青, 谢琼虹, 尚达, 戴淑琪, 朱彤莹.胎球蛋白A对腹膜透析患者冠状动脉钙化发生起始的影响因素分析[J]. 内科理论与实践, 2021, 16(01): 49-52.
[8]	余舒文, 方正滢, 谢静远.基因检测在慢性肾脏病诊治中的应用及进展[J]. 诊断学理论与实践, 2020, 19(06): 613-617.
[9]	李贵森.2019年《中国慢性肾脏病矿物质和骨异常诊治指南》解读[J]. 诊断学理论与实践, 2020, 19(03): 229-231.
[10]	吴颖为, 杨功鑫, 杨星, 谢静远.基于多学科协作的住院医师规范化培训在头颈肿瘤影像学教学中的应用探讨[J]. 诊断学理论与实践, 2020, 19(02): 206-208.
[11]	李娅, 徐静, 张春丽, 王朝晖, 王伟铭,.IgA肾病患者清晨高血压与肾功能关系的研究[J]. 内科理论与实践, 2020, 15(01): 45-48.
[12]	闫梓乔, 周继点, 易黎, 洪永刚, 刘启志, 辛诚.巨大骶前囊肿的外科诊治（附1例报告）[J]. 外科理论与实践, 2020, 25(01): 77-78.
[13]	王斌，孙滨，刘新梦，韩刚，郭芮吉，崔恒庆，方霞，孙文海.手外科多学科联合诊治教学模式的建立与实施[J]. 组织工程与重建外科杂志, 2019, 15(1): 61-62.
[14]	毕宇芳,.2型糖尿病合并慢性肾脏病患者口服降糖药治疗中国专家共识（2019年更新版）解读[J]. 内科理论与实践, 2019, 14(06): 333-336.
[15]	沈坤炜, 曹健, 李宏为.新一代信息技术与乳腺癌诊治模式的变革[J]. 外科理论与实践, 2019, 24(05): 377-377.